David R. Sibley

National Institutes of Health, Bethesda, MD 
"David Sibley"
Mean distance: 14.77 (cluster 11)


Sign in to add mentor
Arthur Stephen Dahms grad student 1975-1977 San Diego State University/USCD (Chemistry Tree)
Ian Creese grad student 1978-1982 UCSD
Robert J. Lefkowitz post-doc 1983-1987 Duke


Sign in to add trainee
Nora Madaras research assistant 2021-2023 NIH
Amy E. Moritz post-doc NIH (Chemistry Tree)
Kathryn D. Luderman post-doc 2014- NIH
Emmanuel O. Akano post-doc 2016- NIH
Marta Sanchez Soto post-doc 2017- NIH
Ana Lucia  Marques Ventura post-doc 1994-1996 NIH
Lisa A. Hazelwood post-doc 2004-2010 NIH
R Benjamin Free research scientist 2003- NIH
David M. Cabrera research scientist 2000-2009 NIH
Marilyn M. Day research scientist 2016-2018 NIH
Blair K. A. research scientist 2017-2018 NIH
Caroline A Cuoco research scientist 2017-2019 NIH
Kayla A. Schardien research scientist 2018-2020 NIH
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Sibley DR, Nilson AN, Moritz AE, et al. (2023) Dopamine receptor divergence revealed using a common ligand. Trends in Pharmacological Sciences
Enriquez-Traba J, Yarur-Castillo HE, Flores RJ, et al. (2023) Dissociable control of motivation and reinforcement by distinct ventral striatal dopamine receptors. Biorxiv : the Preprint Server For Biology
Moritz AE, Madaras NS, Rankin ML, et al. (2023) Delineation of G Protein-Coupled Receptor Kinase Phosphorylation Sites within the D Dopamine Receptor and Their Roles in Modulating β-Arrestin Binding and Activation. International Journal of Molecular Sciences. 24
Free RB, Nilson AN, Boldizsar NM, et al. (2022) Identification and Characterization of ML321: A Novel and Highly Selective D Dopamine Receptor Antagonist with Efficacy in Animal Models That Predict Atypical Antipsychotic Activity. Acs Pharmacology & Translational Science. 6: 151-170
Aslanoglou D, Bertera S, Friggeri L, et al. (2022) Dual pancreatic adrenergic and dopaminergic signaling as a therapeutic target of bromocriptine. Iscience. 25: 104771
Free RB, Cuoco CA, Xie B, et al. (2021) Pharmacological characterization of the imipridone anti-cancer drug ONC201 reveals a negative allosteric mechanism of action at the D dopamine receptor. Molecular Pharmacology
Sibley DR, Luderman KD, Free RB, et al. (2021) Novel Cryo-EM structures of the D1 dopamine receptor unlock its therapeutic potential. Signal Transduction and Targeted Therapy. 6: 205
Aslanoglou D, Bertera S, Sánchez-Soto M, et al. (2021) Dopamine regulates pancreatic glucagon and insulin secretion via adrenergic and dopaminergic receptors. Translational Psychiatry. 11: 59
Luderman KD, Jain P, Benjamin Free R, et al. (2020) Development of Pyrimidone D1 Dopamine Receptor Positive Allosteric Modulators. Bioorganic & Medicinal Chemistry Letters. 127696
Moritz AE, Bonifazi A, Guerrero AM, et al. (2020) Evidence for a stereoselective mechanism for bitopic activity by extended-length antagonists of the D3 dopamine receptor. Acs Chemical Neuroscience
See more...